yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q28704122-06891A4F-80C8-4D55-8E12-FEF6802C9600
Q28704122-06891A4F-80C8-4D55-8E12-FEF6802C9600
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28704122-06891A4F-80C8-4D55-8E12-FEF6802C9600
A novel estimation of the relative economic value in terms of different chronic hepatitis B treatment options
P2860
Q28704122-06891A4F-80C8-4D55-8E12-FEF6802C9600
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28704122-06891A4F-80C8-4D55-8E12-FEF6802C9600
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1ad31a773d341cacbdc6860e35cfa458a595c843
P2860
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.